Vanda Pharmaceuticals Inc. (VNDA)

Name: Vanda Pharmaceuticals Inc. (VNDA) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001347178 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Vanda Pharmaceuticals Inc. reported revenue of $216.10M. Revenue grew 8.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $215.72M.

Key ratios (year ended 2025-12-31)

-70.0%

Operating margin

-102.0%

Net margin

-67.4%

Return on year-end equity

8.7%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-06

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$215.72M	$216.10M	$198.77M	$192.64M	$254.38M	$268.68M	$248.17M	$227.19M	$193.12M	$165.08M	$146.02M
R&D Expense	$116.96M	$109.27M	$74.43M	$76.82M	$85.77M	$75.36M	$55.58M	$48.65M	$43.59M	$38.55M	$29.16M
Operating Income	-$185.67M	-$151.17M	-$40.66M	-$13.95M	$6.33M	$42.16M	$27.24M	$22.81M	$21.74M	-$16.90M	-$18.57M
Net Income	-$274.85M	-$220.47M	-$18.90M	$2.51M	$6.28M	$33.15M	$23.34M	$115.55M	$25.21M	-$15.57M	-$18.01M
EPS (Diluted)	n/a	-$3.74	-$0.33	$0.04	$0.11	$0.58	$0.42	$2.11	$0.48	-$0.35	-$0.41
Total Assets	$412.47M	$488.95M	$656.20M	$648.44M	$634.25M	$593.79M	$533.46M	$483.75M	$332.13M	$205.43M	$210.37M
Total Liabilities	$192.28M	$161.76M	$117.66M	$103.53M	$107.05M	$88.86M	$80.19M	$72.80M	$56.71M	$74.04M	$79.04M
Shareholders' Equity	$220.19M	$327.19M	$538.55M	$544.91M	$527.20M	$504.93M	$453.27M	$410.94M	$275.42M	$131.39M	$131.33M
Cash & Equivalents	$55.88M	$84.85M	$102.32M	$135.82M	$135.03M	$52.07M	$61.03M	$45.07M	$61.01M	$33.63M	$40.43M
Operating Cash Flow	-$142.33M	-$109.44M	-$15.76M	$12.80M	$31.98M	$64.21M	$51.77M	$45.95M	$29.99M	-$1.98M	-$8.10M
Capital Expenditures	$674.0K	$998.0K	$490.0K	$383.0K	$679.0K	$552.0K	$1.79M	$1.02M	$368.0K	$1.66M	$1.41M
Free Cash Flow	-$143.00M	-$110.44M	-$16.25M	$12.42M	$31.30M	$63.66M	$49.98M	$44.93M	$29.62M	-$3.65M	-$9.51M
Shares Outstanding	60.45M	59.10M	58.31M	57.53M	56.78M	55.90M	54.87M	53.55M	52.48M	44.94M	44.00M
Weighted Average Diluted Shares	n/a	58.93M	58.15M	57.56M	56.98M	56.92M	55.19M	54.85M	53.05M	44.74M	43.45M
EPS (Basic)	n/a	-$3.74	-$0.33	$0.04	$0.11	$0.60	$0.43	$2.17	$0.50	-$0.35	-$0.41

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView